OTC/SmallCap IRW
HIGHWAY HOLDINGS REPORTS SECOND QUARTER FISCAL YEAR 2026 RESULTS
HONG KONG, Dec. 15, 2025 /PRNewswire/ -- Highway Holdings Limited (Nasdaq: HIHO, the "Company" or "Highway Holdings") today reported results for the second quarter of fiscal year 2026 and the six months endedSeptember 30, 2025. Net sales for the second quarter of fiscal year 2026 were $1.18 milli...
2025-12-15 20:00
3177
ReTo Eco-Solutions Subsidiary Showcases Equipment and Intelligent Solutions at Excon 2025 to Advance India Market Presence
BEIJING, Dec. 12, 2025 /PRNewswire/ -- ReTo Eco-Solutions, Inc. (Nasdaq: RETO) ("ReTo" or the "Company") today announced that its wholly owned subsidiary, Beijing REIT Equipment Technology Co., Ltd. ("REIT Equipment"), is participating in Excon 2025, a major construction equipment exhibition in B...
2025-12-12 21:00
3826
Locksley Commences Engineering Partner Selection Process for Its Desert Antimony Mine
SAN BERNARDINO, Calif., Dec. 11, 2025 /PRNewswire/ -- Locksley Resources Ltd. (ASX: LKY; OTCQX: LKYRF) announced the company has formally commenced the engineering partner selection process for the upcoming engineering scoping pilot plant design, following direct engagement with Tier 1 U.S. servi...
2025-12-11 21:45
3573
Kazia Therapeutics Highlights New Clinical and Translational Findings Demonstrating Paxalisib's Ability to Reinvigorate Anti-Tumor Immunity Across Multiple Advanced Breast Cancer Populations including TNBC and HER2+
First patient from TNBC trial demonstrated 76% tumor volume shrinkage with corresponding reductions in circulating tumor cells (CTC) and clusters Reinvigoration of immune system + turning cold tumors hot Preliminary ex-vivo data in HER2+ patients demonstrates immune reinvigoration and reductions...
2025-12-10 21:00
5934
ALR TECHNOLOGIES TO RELAUNCH THE GLUCURVE PET CGM IN JANUARY 2026
SINGAPORE, Dec. 8, 2025 /PRNewswire/ -- ALR Technologies SG Ltd ("ALRT" or the " Company") (OTC: ALRTF), the diabetes management company, announces the successful completion of internal manufacturing testing on the GluCurve Pet CGM ("GluCurve") showing accuracy results comparative to the leading v...
2025-12-08 22:14
3032
Locksley Announces Oversubscribed A$17 Million Placement Lead by U.S. Investors Funding to Accelerate Execution of Locksley's U.S. Mine to Market Strategy
SAN BERNARDINO, Calif., Dec. 8, 2025 /PRNewswire/ -- Locksley Resources Limited (ASX: LKY/OTCQX: LKYRF/ADR: LKYLY) announced the successful completion of a heavily oversubscribed capital raising, securing firm commitments to raise approximatelyA$17 million via a placement of new shares at A$0.24 ...
2025-12-08 21:30
3139
Marvion Inc. Signs Exclusive Client Referral MOU with STAR Warehouse Engineering Limited, Strengthening Warehouse Engineering, Logistics Capacity and Corporate Client Acquisition
HONG KONG, Dec. 5, 2025 /PRNewswire/ -- Marvion Inc. (OTCQB: MVNC) today announced that it has entered into a12-month binding Memorandum of Understanding (MOU) with STAR Warehouse Engineering Limited ("STAR"). Under the agreement, STAR willexclusively and with priority refer its engineering clien...
2025-12-05 21:18
4623
China Automotive Systems Advances High-Torque Intelligent Steering Motors to Mass Production for Commercial Vehicles
WUHAN, China, Dec. 5, 2025 /PRNewswire/ -- China Automotive Systems, Inc. (NASDAQ: CAAS) ("CAAS" or the "Company"), a leading power steering components and systems supplier inChina, today announced that its subsidiary, Hyoseong ( Wuhan) Motion Mechatronics System Co. Ltd., has entered the final co...
2025-12-05 19:00
3970
PINTEC TO HOLD EXTRAORDINARY GENERAL MEETING ON JANUARY 8, 2026
BEIJING, Dec. 4, 2025 /PRNewswire/ -- Pintec Technology Holdings Limited (NASDAQ: PT) ("Pintec" or the "Company"), a technology platform committed to enabling innovative financial and digital solutions for businesses worldwide, today announced that the Company will hold its extraordinary general ...
2025-12-05 05:00
3609
Kazia Therapeutics Announces Pricing of $50.0 Million Private Placement of Equity Securities
SYDNEY, Dec. 2, 2025 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA), an oncology-focused drug development company, today announced that it has entered into a securities purchase agreement with certain established institutional and accredited investors for a private placement of equity ...
2025-12-02 22:00
3823
MaxsMaking Inc. Addresses SEC Trading Suspension and Affirms Full Cooperation with Regulators
SHANGHAI, Dec. 1, 2025 /PRNewswire/ -- MaxsMaking Inc. (Nasdaq: MAMK) ("MaxsMaking" or the "Company"), a manufacturer of customized consumer goods with a focus on advanced technology and innovation, addresses the ten-day Order of Suspension of Trading in the securities of the Company entered by t...
2025-12-01 19:00
2449
CN Energy Group. Inc. Announces Launch of PATHENBOT Robotics Solutions Platform and PATHENBOT's Official Website
LISHUI, China, Dec. 1, 2025 /PRNewswire/ -- CN Energy Group. Inc. ("CNEY" or the "Company") (NASDAQ: CNEY), a Nasdaq-listed company, today announced that its wholly owned subsidiary, PATHENBOT Group Inc. ("PATHENBOT"), has launched its robotics solutions platform and its official website (www.pat...
2025-12-01 18:55
3773
Nagarro expands in Japan with the acquisition of Inaho Digital Solutions
TOKYO, Nov. 26, 2025 /PRNewswire/ -- Nagarro, a global leader in digital engineering, announced today the acquisition of Inaho Digital Solutions (IDS), a boutique IT service provider specialized in modernizing legacy applications and in SAP S/4HANA transformations inJapan and for Japanese clients...
2025-11-26 19:06
2426
Marvion Inc. (OTC: MVNC) Delivers Strong Q3 Profitability and Secures New HK$720,000 Annual Storage Contract with Client Relocating to New Warehouse on 1 January 2026
HONG KONG, Nov. 24, 2025 /PRNewswire/ -- Marvion Inc. (OTCQB: MVNC) is pleased to announce two major milestones that further strengthen the Company's financial momentum and long-term growth outlook. Q3 Results: Revenue Growth Over 140% and Return to Profitability Based on the Company's recently ...
2025-11-24 21:14
3243
Kazia Therapeutics Achieves Initial iCR (Immune-Complete Response) in Metastatic TNBC and Delivers Q4 Business Update with Breakthroughs Across Breast Cancer, Immuno-Oncology, and GBM Regulatory Strategy
SYDNEY, Nov. 18, 2025 /PRNewswire/ -- Kazia Therapeutics Limited (Nasdaq: KZIA), an oncology-focused drug development company, today announced that a patient with stage IV triple-negative breast cancer (TNBC) treated under an FDA-authorized single-patient expanded access protocol combining paxali...
2025-11-19 05:15
3609
Datasea Inc. Issues Statement Regarding Recent Market Activity
BEIJING, Nov. 18, 2025 /PRNewswire/ -- Datasea Inc. (NASDAQ: DTSS) ("Datasea" or the "Company") ,aNevada-based high-tech enterprise engaged in acoustic technologies and AI multimodal digitalization, today issues a brief statement regarding recent trading activity in its common stock. The Company...
2025-11-18 22:30
3370
Locksley Enters into Sponsored Research Agreement with Columbia University to Develop Advanced Sustainable Processing Technologies for Rare Earth Elements (REE) and Critical Metal Recovery
SAN BERNARDINO, Calif., Nov. 17, 2025 /PRNewswire/ -- Locksley Resources, Ltd. (ASX: LKY; OTCQX: LKYRF) announced the company has formalized a research collaboration withColumbia University, one of the United States' premier institutions in sustainable mineral processing, to advance next-generati...
2025-11-17 21:35
2049
ReTo Eco-Solutions, Inc. to Hold Its Annual Meeting of Shareholders at Its Headquarters on December 23, 2025 Beijing Time
BEIJING, Nov. 13, 2025 /PRNewswire/ -- ReTo Eco-Solutions, Inc. (Nasdaq: RETO) ("ReTo" or the "Company"), today announced that it plans to hold its 2025 Annual Meeting of Shareholders (the "Meeting") on December 23, 2025 (Beijing Time). Shareholders as of the record date, close of business onNove...
2025-11-14 05:15
2822
Locksley Advances Toward US Antimony Production
Fast-track execution positions Locksley among leaders in restoring America's antimony supply chain and processing capabilities. SAN BERNARDINO, Calif., Nov. 13, 2025 /PRNewswire/ -- Locksley Resources, Ltd. (ASX: LKY; OTCQX: LKYRF) provided an update on the company's progress and immediate plans...
2025-11-13 21:20
2927
EirGenix Signed The Commercial Licensing Agreement for Its Second HER2 Biosimilar Asset EG1206A
TAIPEI, Nov. 12, 2025 /PRNewswire/ -- EirGenix Inc.(TWSE: 6589) today announced that it has entered into a second global exclusive licensing agreement with international biosimilar leader Sandoz AG (SIX:SDZ/OTCQX:SDZNY) for the commercialization of its independently developed breast cancer biosim...
2025-11-12 20:47
1646
Week's Top Stories
Most Reposted
Global virtual travel card program launched by Visa and Trip.com to make travel payments simpler and more seamless in Asia Pacific
[Picked up by 333 media titles]
2026-03-11 11:08PDG Targets USD 5 Billion Debt Raise
[Picked up by 297 media titles]
2026-03-11 10:00The Mastercard Collection: Savor the Extraordinary with Mastercard's Asia Gourmet Circle Program
[Picked up by 295 media titles]
2026-03-12 09:00Five Breakthrough AV Technologies: Dreame's Premium AV Brand INNIX Highlights a High-End Home Cinema Lineup at AWE 2026
[Picked up by 284 media titles]
2026-03-13 16:08
Travel providers to accept UnionPay cards for both direct e-Commerce bookings and in-direct sales via Amadeus Travel Platform
[Picked up by 283 media titles]
2026-03-12 11:00
Most Read
HTCO Launches U.S. Strategic Initiative Led by Chairman Christopher Nixon Cox, Establishes Independent Governance Committee for U.S. Operations
2026-03-13 21:30
6796
Insilico Medicine to Announce 2025 Financial Results on March 30, 2026
2026-03-13 21:59
6057